{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:18:20Z","timestamp":1786634300973,"version":"build-2736575974"},"reference-count":203,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":2955,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatic fibrosis is commonly diagnosed in dogs, often as a sequela to chronic hepatitis (CH). The development of fibrosis is a crucial event in the progression of hepatic disease that is of prognostic value. The pathophysiology of hepatic fibrosis in human patients and rodent models has been studied extensively. Although less is known about this process in dogs, evidence suggests that fibrogenic mechanisms are similar between species and that activation of hepatic stellate cells is a key step. Diagnosis and staging of hepatic fibrosis in dogs requires histopathological examination of a liver biopsy specimen. However, performing a liver biopsy is invasive and assessment of fibrotic stage is complicated by the absence of a universally accepted staging scheme in veterinary medicine. Serum biomarkers that can discriminate among different fibrosis stages are used in human patients, but such markers must be more completely evaluated in dogs before clinical use. When successful treatment of its underlying cause is feasible, reversal of hepatic fibrosis has been shown to be possible in rodent models and human patients. Reversal of fibrosis has not been well documented in dogs, but successful treatment of CH is possible. In human medicine, better understanding of the pathomechanisms of hepatic fibrosis is leading to the development of novel treatment strategies. In time, these may be applied to dogs. This article comparatively reviews the pathogenesis of hepatic fibrosis, its diagnosis, and its treatment in dogs.<\/jats:p>","DOI":"10.1111\/jvim.14891","type":"journal-article","created":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T11:44:34Z","timestamp":1512042274000},"page":"26-41","source":"Crossref","is-referenced-by-count":49,"title":["Hepatic Fibrosis in Dogs"],"prefix":"10.1093","volume":"32","author":[{"given":"V.M.","family":"Eulenberg","sequence":"first","affiliation":[{"name":"Gastrointestinal Laboratory, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University , College Station, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5107-4577","authenticated-orcid":false,"given":"J.A.","family":"Lidbury","sequence":"additional","affiliation":[{"name":"Gastrointestinal Laboratory, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University , College Station, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,1]]},"reference":[{"key":"2026020303253714400_jvim14891-bib-0001","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1440-1746.2008.05345.x","article-title":"Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?","volume":"23","author":"Gressner","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0002","article-title":"Oxford Textbook of Clinical Hepatology","author":"Bircher","year":"1999","edition":"2"},{"key":"2026020303253714400_jvim14891-bib-0003","first-page":"297","article-title":"Schiff's Diseases of the Liver","author":"Friedman","year":"2007","edition":"10"},{"key":"2026020303253714400_jvim14891-bib-0004","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/hep.23315","article-title":"Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long-term treatment against cirrhosis trial","volume":"51","author":"Everhart","year":"2010","journal-title":"Hepatology"},{"key":"2026020303253714400_jvim14891-bib-0005","first-page":"E178","article-title":"Liver fibrosis progression predicts survival in patients with primary biliary cirrhosis","volume":"43","author":"Namisaki","year":"2017","journal-title":"Hepatol Res"},{"key":"2026020303253714400_jvim14891-bib-0006","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cvsm.2009.02.007","article-title":"Important clinical syndromes associated with liver disease","volume":"39","author":"Rothuizen","year":"2009","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303253714400_jvim14891-bib-0007","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1748-5827.2010.00996.x","article-title":"Prevalence of hepatic lesions at post-mortem examination in dogs and association with pancreatitis","volume":"51","author":"Watson","year":"2010","journal-title":"J Small Anim Pract"},{"key":"2026020303253714400_jvim14891-bib-0008","first-page":"258","article-title":"Jubb, Kennedy & Palmer's Pathology of Domestic Animals","author":"Cullen","year":"2015","edition":"6"},{"key":"2026020303253714400_jvim14891-bib-0009","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0010","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/qjmed\/hcs069","article-title":"Liver fibrosis: A bidirectional model of fibrogenesis and resolution","volume":"105","author":"Ramachandran","year":"2012","journal-title":"QJM"},{"key":"2026020303253714400_jvim14891-bib-0011","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/1040638716658499","article-title":"Sinusoidal endothelial cell and hepatic stellate cell phenotype correlates with stage of fibrosis in chronic liver disease in dogs","volume":"28","author":"Vince","year":"2016","journal-title":"J Vet Diagn Invest"},{"key":"2026020303253714400_jvim14891-bib-0012","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1053\/j.gastro.2004.03.009","article-title":"Spontaneous recovery from micronodular cirrhosis: Evidence for incomplete resolution associated with matrix cross-linking","volume":"126","author":"Issa","year":"2004","journal-title":"Gastroenterology"},{"key":"2026020303253714400_jvim14891-bib-0013","first-page":"1637","article-title":"Textbook of Veterinary Internal Medicine: Diseases of the Dog and the Cat","author":"Willard","year":"2010","edition":"7"},{"key":"2026020303253714400_jvim14891-bib-0014","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.dld.2004.01.003","article-title":"Liver fibrosis: From the bench to clinical targets","volume":"36","author":"Pinzani","year":"2004","journal-title":"Dig Liver Dis"},{"key":"2026020303253714400_jvim14891-bib-0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.redox.2015.07.005","article-title":"Role of NADPH oxidases in the redox biology of liver fibrosis","volume":"6","author":"Crosas-Molist","year":"2015","journal-title":"Redox Biol"},{"key":"2026020303253714400_jvim14891-bib-0016","doi-asserted-by":"crossref","first-page":"E3297","DOI":"10.1073\/pnas.1400062111","article-title":"Origin of myofibroblasts in the fibrotic liver in mice","volume":"111","author":"Iwaisako","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020303253714400_jvim14891-bib-0017","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1354\/vp.38-6-628","article-title":"Characterization of the inflammatory infiltrate in canine chronic hepatitis","volume":"38","author":"Boisclair","year":"2001","journal-title":"Vet Pathol"},{"key":"2026020303253714400_jvim14891-bib-0018","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"2026020303253714400_jvim14891-bib-0019","doi-asserted-by":"crossref","first-page":"C789","DOI":"10.1152\/ajpcell.00230.2013","article-title":"Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis","volume":"305","author":"Mallat","year":"2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"2026020303253714400_jvim14891-bib-0020","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3748\/wjg.v20.i10.2515","article-title":"Hepatic inflammation and progressive liver fibrosis in chronic liver disease","volume":"20","author":"Czaja","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2026020303253714400_jvim14891-bib-0021","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199306243282508","article-title":"Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies","volume":"328","author":"Friedman","year":"1993","journal-title":"N Engl J Med"},{"key":"2026020303253714400_jvim14891-bib-0022","doi-asserted-by":"crossref","first-page":"e2331","DOI":"10.1053\/j.gastro.2009.02.081","article-title":"Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis","volume":"136","author":"Oakley","year":"2009","journal-title":"Gastroenterology"},{"key":"2026020303253714400_jvim14891-bib-0023","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1354\/vp.44-6-803","article-title":"Tenascin-C in chronic canine hepatitis: Immunohistochemical localization and correlation with necro-inflammatory activity, fibrotic stage, and expression of alpha-smooth muscle actin, cytokeratin 7, and CD3 + cells","volume":"44","author":"Mekonnen","year":"2007","journal-title":"Vet Pathol"},{"key":"2026020303253714400_jvim14891-bib-0024","first-page":"42","article-title":"\u03b1-SMA and Ki-67 immunohistochemistry as indicators for the fibrotic remodeling process in the liver of dogs","volume":"2","author":"Neumann","year":"2012","journal-title":"J Adv Vet Anim Res"},{"key":"2026020303253714400_jvim14891-bib-0025","first-page":"879","article-title":"Canine & Feline Gastroenterology","author":"Johnson","year":"2013"},{"key":"2026020303253714400_jvim14891-bib-0026","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jhep.2016.01.010","article-title":"Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers","volume":"64","author":"Lua","year":"2016","journal-title":"J Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0027","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40139-014-0054-y","article-title":"Portal fibroblasts in biliary fibrosis","volume":"2","author":"Wells","year":"2014","journal-title":"Curr Pathobiol Rep"},{"key":"2026020303253714400_jvim14891-bib-0028","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00441-016-2443-5","article-title":"Portal myofibroblasts connect angiogenesis and fibrosis in liver","volume":"365","author":"Lemoinne","year":"2016","journal-title":"Cell Tissue Res"},{"key":"2026020303253714400_jvim14891-bib-0029","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/hep.27318","article-title":"Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles","volume":"61","author":"Lemoinne","year":"2015","journal-title":"Hepatology"},{"key":"2026020303253714400_jvim14891-bib-0030","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"2026020303253714400_jvim14891-bib-0031","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/MOG.0b013e32834550b4","article-title":"Hedgehog signaling in cholangiocytes","volume":"27","author":"Omenetti","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"2026020303253714400_jvim14891-bib-0032","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2010.10.003","article-title":"Hedgehog signaling in the liver","volume":"54","author":"Omenetti","year":"2011","journal-title":"J Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0033","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.biocel.2010.10.015","article-title":"The role of hedgehog signaling in fibrogenic liver repair","volume":"43","author":"Choi","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"2026020303253714400_jvim14891-bib-0034","doi-asserted-by":"crossref","first-page":"e45285","DOI":"10.1371\/journal.pone.0045285","article-title":"NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development","volume":"7","author":"Sancho","year":"2012","journal-title":"PLoS One"},{"key":"2026020303253714400_jvim14891-bib-0035","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/hep.24206","article-title":"Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis","volume":"53","author":"Chu","year":"2011","journal-title":"Hepatology"},{"key":"2026020303253714400_jvim14891-bib-0036","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/hep.23368","article-title":"Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice","volume":"51","author":"Taura","year":"2010","journal-title":"Hepatology"},{"key":"2026020303253714400_jvim14891-bib-0037","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jhep.2007.01.029","article-title":"Pro-fibrogenic potential of PDGF-D in liver fibrosis","volume":"46","author":"Borkham-Kamphorst","year":"2007","journal-title":"J Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0038","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cytogfr.2015.10.002","article-title":"The PDGF system and its antagonists in liver fibrosis","volume":"28","author":"Borkham-Kamphorst","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"2026020303253714400_jvim14891-bib-0039","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-2001-17554","article-title":"Cytokine receptors and signaling in hepatic stellate cells","volume":"21","author":"Pinzani","year":"2001","journal-title":"Semin Liver Dis"},{"key":"2026020303253714400_jvim14891-bib-0040","doi-asserted-by":"crossref","first-page":"G1051","DOI":"10.1152\/ajpgi.00058.2005","article-title":"PI3K is involved in PDGF-beta receptor upregulation post-PDGF-BB treatment in mouse HSC","volume":"291","author":"Lechuga","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2026020303253714400_jvim14891-bib-0041","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1083\/jcb.92.2.584","article-title":"Platelet-derived growth factor in chemotactic for fibroblasts","volume":"92","author":"Seppa","year":"1982","journal-title":"J Cell Biol"},{"key":"2026020303253714400_jvim14891-bib-0042","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1177\/0300985810388523","article-title":"Expression of fibrosis-related genes in canine chronic hepatitis","volume":"48","author":"Kanemoto","year":"2011","journal-title":"Vet Pathol"},{"key":"2026020303253714400_jvim14891-bib-0043","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.2005.088690","article-title":"Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis","volume":"56","author":"Inagaki","year":"2007","journal-title":"Gut"},{"key":"2026020303253714400_jvim14891-bib-0044","doi-asserted-by":"crossref","first-page":"G605","DOI":"10.1152\/ajpgi.00222.2012","article-title":"Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury","volume":"304","author":"Perepelyuk","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2026020303253714400_jvim14891-bib-0045","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1478-3231.2006.01277.x","article-title":"Transforming growth factor beta-1 signalling in canine hepatic diseases: New models for human fibrotic liver pathologies","volume":"26","author":"Spee","year":"2006","journal-title":"Liver Int"},{"key":"2026020303253714400_jvim14891-bib-0046","first-page":"428","article-title":"Plasma concentration of transforming growth factor-beta1 and hepatic fibrosis in dogs","volume":"72","author":"Neumann","year":"2008","journal-title":"Can J Vet Res"},{"key":"2026020303253714400_jvim14891-bib-0047","doi-asserted-by":"crossref","first-page":"e0176826","DOI":"10.1371\/journal.pone.0176826","article-title":"Gene expression patterns in the progression of canine copper-associated chronic hepatitis","volume":"12","author":"Dirksen","year":"2017","journal-title":"PLoS One"},{"key":"2026020303253714400_jvim14891-bib-0048","doi-asserted-by":"crossref","first-page":"8848","DOI":"10.1074\/jbc.M313204200","article-title":"Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan","volume":"279","author":"Gao","year":"2004","journal-title":"J Biol Chem"},{"key":"2026020303253714400_jvim14891-bib-0049","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2893.2009.01110.x","article-title":"Validation of connective tissue growth factor (CTGF\/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis","volume":"16","author":"Kovalenko","year":"2009","journal-title":"J Viral Hepat"},{"key":"2026020303253714400_jvim14891-bib-0050","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.yjmcc.2004.04.022","article-title":"Phenylephrine and endothelin-1 upregulate connective tissue growth factor in neonatal rat cardiac myocytes","volume":"37","author":"Kemp","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"2026020303253714400_jvim14891-bib-0051","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.prp.2016.11.004","article-title":"Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis","volume":"213","author":"Sferra","year":"2017","journal-title":"Pathol Res Pract"},{"key":"2026020303253714400_jvim14891-bib-0052","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/europace\/eus052","article-title":"Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model","volume":"14","author":"Kiryu","year":"2012","journal-title":"Europace"},{"key":"2026020303253714400_jvim14891-bib-0053","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0945-053X(02)00055-0","article-title":"Gene regulation of connective tissue growth factor: New targets for antifibrotic therapy?","volume":"21","author":"Blom","year":"2002","journal-title":"Matrix Biol"},{"key":"2026020303253714400_jvim14891-bib-0054","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/1354750X.2011.561366","article-title":"Connective tissue growth factor (CTGF\/CCN2) ELISA: A novel tool for monitoring fibrosis","volume":"16","author":"Dendooven","year":"2011","journal-title":"Biomarkers"},{"key":"2026020303253714400_jvim14891-bib-0055","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/gast.1996.v110.pm8566602","article-title":"Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells","volume":"110","author":"Pinzani","year":"1996","journal-title":"Gastroenterology"},{"key":"2026020303253714400_jvim14891-bib-0056","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.510270222","article-title":"Cellular localization of endothelin-1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells","volume":"27","author":"Rockey","year":"1998","journal-title":"Hepatology"},{"key":"2026020303253714400_jvim14891-bib-0057","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/jvim.14687","article-title":"Hepatic and plasma endothelin-1 in dogs with chronic hepatitis","volume":"31","author":"Sakamoto","year":"2017","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0058","doi-asserted-by":"crossref","first-page":"936486","DOI":"10.1155\/2012\/936486","article-title":"Reactive oxygen species in health and disease","volume":"2012","author":"Alfadda","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"2026020303253714400_jvim14891-bib-0059","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.abb.2007.04.016","article-title":"NOX in liver fibrosis","volume":"462","author":"De Minicis","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"2026020303253714400_jvim14891-bib-0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fphys.2016.00017","article-title":"The role of NADPH oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts","volume":"7","author":"Liang","year":"2016","journal-title":"Front Physiol"},{"key":"2026020303253714400_jvim14891-bib-0061","doi-asserted-by":"crossref","first-page":"e0129743","DOI":"10.1371\/journal.pone.0129743","article-title":"Deficiency of NOX1 or NOX4 prevents liver inflammation and fibrosis in mice through inhibition of hepatic stellate cell activation","volume":"10","author":"Lan","year":"2015","journal-title":"PLoS One"},{"key":"2026020303253714400_jvim14891-bib-0062","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/j.gastro.2015.04.009","article-title":"Hepatocyte nicotinamide adenine dinucleotide phosphate reduced oxidase 4 regulates stress signaling, fibrosis, and insulin sensitivity during development of steatohepatitis in mice","volume":"149","author":"Bettaieb","year":"2015","journal-title":"Gastroenterology"},{"key":"2026020303253714400_jvim14891-bib-0063","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2460\/ajvr.2002.63.1187","article-title":"Liver glutathione concentrations in dogs and cats with naturally occurring liver disease","volume":"63","author":"Center","year":"2002","journal-title":"Am J Vet Res"},{"key":"2026020303253714400_jvim14891-bib-0064","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1440-1746.2008.05461.x","article-title":"Liver disease and the renin-angiotensin system: Recent discoveries and clinical implications","volume":"23","author":"Lubel","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0065","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-12-0341","article-title":"Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: New players of the renin-angiotensin system","volume":"216","author":"Santos","year":"2013","journal-title":"J Endocrinol"},{"key":"2026020303253714400_jvim14891-bib-0066","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00029330-200801020-00013","article-title":"Effect of angiotensin II and angiotensin II type 1 receptor antagonist on the proliferation, contraction and collagen synthesis in rat hepatic stellate cells","volume":"121","author":"Liu","year":"2008","journal-title":"Chin Med J"},{"key":"2026020303253714400_jvim14891-bib-0067","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0016-5085(03)00695-4","article-title":"Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II","volume":"125","author":"Bataller","year":"2003","journal-title":"Gastroenterology"},{"key":"2026020303253714400_jvim14891-bib-0068","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2006.10.018","article-title":"The renin-angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1-7)","volume":"46","author":"Pereira","year":"2007","journal-title":"J Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0069","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/CS20080647","article-title":"Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat","volume":"117","author":"Lubel","year":"2009","journal-title":"Clin Sci"},{"key":"2026020303253714400_jvim14891-bib-0070","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/gast.2001.25480","article-title":"Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis","volume":"121","author":"Jonsson","year":"2001","journal-title":"Gastroenterology"},{"key":"2026020303253714400_jvim14891-bib-0071","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.bjp.0705339","article-title":"An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells","volume":"139","author":"Kurikawa","year":"2003","journal-title":"Br J Pharmacol"},{"key":"2026020303253714400_jvim14891-bib-0072","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0035-1550057","article-title":"Resolution of liver fibrosis: Basic mechanisms and clinical relevance","volume":"35","author":"Ramachandran","year":"2015","journal-title":"Semin Liver Dis"},{"key":"2026020303253714400_jvim14891-bib-0073","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biopha.2016.03.042","article-title":"Silymarin-loaded Eudragit RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats","volume":"81","author":"Younis","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"2026020303253714400_jvim14891-bib-0074","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: Exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J Clin Invest"},{"key":"2026020303253714400_jvim14891-bib-0075","first-page":"176","article-title":"Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis","volume":"24","author":"Iredale","year":"1996","journal-title":"Hepatology"},{"key":"2026020303253714400_jvim14891-bib-0076","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI115850","article-title":"Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver","volume":"90","author":"Iredale","year":"1992","journal-title":"J Clin Invest"},{"key":"2026020303253714400_jvim14891-bib-0077","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/gast.1996.v110.pm8608892","article-title":"Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver","volume":"110","author":"Benyon","year":"1996","journal-title":"Gastroenterology"},{"key":"2026020303253714400_jvim14891-bib-0078","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1186\/1755-1536-5-S1-S26","article-title":"Reversibility of liver fibrosis","volume":"5","author":"Pellicoro","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"2026020303253714400_jvim14891-bib-0079","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.phrs.2008.06.011","article-title":"Defining therapeutic targets for liver fibrosis: Exploiting the biology of inflammation and repair","volume":"58","author":"Iredale","year":"2008","journal-title":"Pharmacol Res"},{"key":"2026020303253714400_jvim14891-bib-0080","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"2026020303253714400_jvim14891-bib-0081","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cvsm.2009.02.003","article-title":"Summary of the World Small Animal Veterinary Association standardization committee guide to classification of liver disease in dogs and cats","volume":"39","author":"Cullen","year":"2009","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303253714400_jvim14891-bib-0082","article-title":"Morphological classification of parenchymal disorders of the canine and feline liver: hepatocellular death, hepatitis, and cirrhosis-2 (updated version). In: World Small Animal Veterinary Association Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases. Society of Comparative Hepatology","author":"van den Ingh"},{"key":"2026020303253714400_jvim14891-bib-0083","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1939-1676.2008.0215.x","article-title":"Primary hepatitis in dogs: A retrospective review (2002\u20132006)","volume":"23","author":"Poldervaart","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0084","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1354\/vp.08-VP-0197-S-FL","article-title":"Copper-associated hepatitis in Labrador retrievers","volume":"46","author":"Smedley","year":"2009","journal-title":"Vet Pathol"},{"key":"2026020303253714400_jvim14891-bib-0085","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cvsm.2016.11.011","article-title":"Canine copper-associated hepatitis","volume":"47","author":"Dirksen","year":"2017","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303253714400_jvim14891-bib-0086","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cvsm.2016.11.012","article-title":"Canine idiopathic chronic hepatitis","volume":"47","author":"Bexfield","year":"2017","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303253714400_jvim14891-bib-0087","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vetpar.2014.03.026","article-title":"Distribution and characterization of Heterobilharzia americana in dogs in Texas","volume":"203","author":"Rodriguez","year":"2014","journal-title":"Vet Parasitol"},{"key":"2026020303253714400_jvim14891-bib-0088","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2460\/javma.1993.203.05.680","article-title":"Granulomatous hepatitis in dogs: Nine cases (1987\u20131990)","volume":"203","author":"Chapman","year":"1993","journal-title":"J Am Vet Med A"},{"key":"2026020303253714400_jvim14891-bib-0089","doi-asserted-by":"crossref","first-page":"320","DOI":"10.5326\/JAAHA-MS-6210","article-title":"Angiostrongylus vasorum causing severe granulomatous hepatitis with concurrent multiple acquired PSS","volume":"51","author":"Cook","year":"2015","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020303253714400_jvim14891-bib-0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcpa.2004.09.004","article-title":"Chronic hepatitis associated with canine leishmaniosis (Leishmania infantum): A clinicopathological study of 26 cases","volume":"132","author":"Rallis","year":"2005","journal-title":"J Comp Pathol"},{"key":"2026020303253714400_jvim14891-bib-0091","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1292\/jvms.12-0447","article-title":"Histological and immunohistochemical evaluations of lobular dissecting hepatitis in American cocker spaniel dogs","volume":"75","author":"Mizooku","year":"2013","journal-title":"J Vet Med Sci"},{"key":"2026020303253714400_jvim14891-bib-0092","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1939-1676.1994.tb03219.x","article-title":"Lobular dissecting hepatitis in juvenile and young adult dogs","volume":"8","author":"van den Ingh","year":"1994","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0093","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12917-014-0309-1","article-title":"Enhanced Wnt\/beta-catenin and Notch signalling in the activated canine hepatic progenitor cell niche","volume":"10","author":"Schotanus","year":"2014","journal-title":"BMC Vet Res"},{"key":"2026020303253714400_jvim14891-bib-0094","first-page":"241","article-title":"Small Animal Gastroenterology","author":"Rothuizen","year":"2008"},{"key":"2026020303253714400_jvim14891-bib-0095","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/jvim.13974","article-title":"Bacterial cholangitis, cholecystitis, or both in dogs","volume":"30","author":"Tamborini","year":"2016","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0096","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1292\/jvms.10-0448","article-title":"A case of recovery from canine destructive cholangitis in a Miniature Dachshund","volume":"73","author":"Osumi","year":"2011","journal-title":"J Vet Med Sci"},{"key":"2026020303253714400_jvim14891-bib-0097","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1748-5827.2006.00155.x","article-title":"Suspected drug-induced destructive cholangitis in a young dog","volume":"47","author":"Gabriel","year":"2006","journal-title":"J Small Anim Pract"},{"key":"2026020303253714400_jvim14891-bib-0098","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1007\/s11095-012-0690-z","article-title":"Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage","volume":"29","author":"Li","year":"2012","journal-title":"Pharm Res"},{"key":"2026020303253714400_jvim14891-bib-0099","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/0300985815610567","article-title":"Ductal plate malformation in the liver of Boxer dogs: Clinical and histological features","volume":"53","author":"Pillai","year":"2016","journal-title":"Vet Path"},{"key":"2026020303253714400_jvim14891-bib-0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1292\/jvms.15-0425","article-title":"A case report of suspected hepatopulmonary syndrome secondary to ductal plate malformation with chronic active hepatitis in a dog","volume":"78","author":"Kaneko","year":"2016","journal-title":"J Vet Med Sci"},{"key":"2026020303253714400_jvim14891-bib-0101","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/0300985809353313","article-title":"Congenital hepatic fibrosis in 5 dogs","volume":"47","author":"Brown","year":"2010","journal-title":"Vet Path"},{"key":"2026020303253714400_jvim14891-bib-0102","first-page":"936","article-title":"Canine & Feline Gastroenterology","author":"Watson","year":"2013"},{"key":"2026020303253714400_jvim14891-bib-0103","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1740-8261.1980.tb00597.x","article-title":"Indirect and direct determination of the portal vein pressure in normal and abnormal dogs and normal cats","volume":"21","author":"Schmidt","year":"1980","journal-title":"Vet Radiol"},{"key":"2026020303253714400_jvim14891-bib-0104","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1939-1676.2011.00691.x","article-title":"Portal hypertension: Pathophysiology, diagnosis, and treatment","volume":"25","author":"Buob","year":"2011","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0105","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1053\/j.gastro.2008.03.007","article-title":"Portal hypertension and its complications","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"2026020303253714400_jvim14891-bib-0106","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.dld.2005.02.009","article-title":"Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients","volume":"37","author":"Thalheimer","year":"2005","journal-title":"Dig Liver Dis"},{"key":"2026020303253714400_jvim14891-bib-0107","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.510300628","article-title":"Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis","volume":"30","author":"Perello","year":"1999","journal-title":"Hepatology"},{"key":"2026020303253714400_jvim14891-bib-0108","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/j.1939-1676.2007.tb01963.x","article-title":"Esophageal varices due to a probable arteriovenous communication in a dog","volume":"21","author":"Bertolini","year":"2007","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0109","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1939-1676.2008.0230.x","article-title":"Ascites is a negative prognostic indicator in chronic hepatitis in dogs","volume":"23","author":"Raffan","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0110","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/vec.12473","article-title":"Hepatic encephalopathy in dogs and cats","volume":"26","author":"Lidbury","year":"2016","journal-title":"J Vet Emerg Crit Car"},{"key":"2026020303253714400_jvim14891-bib-0111","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1939-1676.1989.tb00863.x","article-title":"Gastroduodenal ulceration in dogs. Retrospective study of 43 cases and literature review","volume":"3","author":"Stanton","year":"1989","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0112","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2460\/javma.244.1.78","article-title":"Endovascular evaluation and treatment of intrahepatic portosystemic shunts in dogs: 100 cases (2001\u20132011)","volume":"244","author":"Weisse","year":"2014","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303253714400_jvim14891-bib-0113","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/vr.100627","article-title":"Serum gastrin concentrations in dogs with liver disorders","volume":"171","author":"Mazaki-Tovi","year":"2012","journal-title":"Vet Rec"},{"key":"2026020303253714400_jvim14891-bib-0114","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2460\/javma.234.7.906","article-title":"Primary bacterial peritonitis in dogs and cats: 24 cases (1990\u20132006)","volume":"234","author":"Culp","year":"2009","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303253714400_jvim14891-bib-0115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4321\/S1130-01082012000400006","article-title":"Chronic hepatitis in man and in dog: A comparative update","volume":"104","author":"Cerquetella","year":"2012","journal-title":"Rev Esp Enferm Dig"},{"key":"2026020303253714400_jvim14891-bib-0116","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1939-1676.2007.tb02925.x","article-title":"Chronic hepatitis in Labrador retrievers: Clinical presentation and prognostic factors","volume":"21","author":"Shih","year":"2007","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0117","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.tvjl.2009.05.009","article-title":"Coagulation disorders in dogs with hepatic disease","volume":"185","author":"Prins","year":"2010","journal-title":"Vet J"},{"key":"2026020303253714400_jvim14891-bib-0118","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/jvim.14639","article-title":"Thromboelastography in dogs with chronic hepatopathies","volume":"31","author":"Fry","year":"2017","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0119","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1939-1676.2012.00893.x","article-title":"Portal vein thrombosis in 33 dogs: 1998-2011","volume":"26","author":"Respess","year":"2012","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0120","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1136\/gut.2003.032136","article-title":"A role for thrombin in liver fibrosis","volume":"53","author":"Duplantier","year":"2004","journal-title":"Gut"},{"key":"2026020303253714400_jvim14891-bib-0121","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bbadis.2012.12.013","article-title":"Coagulation and coagulation signalling in fibrosis","volume":"1832","author":"Mercer","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"2026020303253714400_jvim14891-bib-0122","first-page":"1238","article-title":"Hepatic and portal vein thrombosis in cirrhosis: Possible role in development of parenchymal extinction and portal hypertension","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"2026020303253714400_jvim14891-bib-0123","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1748-5827.1995.tb02801.x","article-title":"Diagnosis and prognosis of chronic hepatitis and cirrhosis in dogs","volume":"36","author":"Sevelius","year":"1995","journal-title":"J Small Anim Pract"},{"key":"2026020303253714400_jvim14891-bib-0124","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/vcp.12352","article-title":"Cytologic features of hepatic fibrosis in dogs: A retrospective study on 22 cases","volume":"45","author":"Masserdotti","year":"2016","journal-title":"Vet Clin Pathol"},{"key":"2026020303253714400_jvim14891-bib-0125","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5326\/15473317-37-3-228","article-title":"Correlation between coagulation profile findings and bleeding complications after ultrasound-guided biopsies: 434 cases (1993\u20131996)","volume":"37","author":"Bigge","year":"2001","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020303253714400_jvim14891-bib-0126","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cvsm.2016.11.007","article-title":"Getting the most out of liver biopsy","volume":"47","author":"Lidbury","year":"2017","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303253714400_jvim14891-bib-0127","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"2026020303253714400_jvim14891-bib-0128","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/jvim.12520","article-title":"Histopathologic variation between liver lobes in dogs","volume":"29","author":"Kemp","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/jvim.12508","article-title":"A comparison of liver sampling techniques in dogs","volume":"29","author":"Kemp","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cvsm.2009.02.006","article-title":"Liver biopsy techniques","volume":"39","author":"Rothuizen","year":"2009","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303253714400_jvim14891-bib-0131","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1309\/W3XCNT4HKFBN2G0B","article-title":"A systematic review of the quality of liver biopsy specimens","volume":"125","author":"Cholongitas","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"2026020303253714400_jvim14891-bib-0132","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0168-8278(03)00191-0","article-title":"Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease","volume":"39","author":"Colloredo","year":"2003","journal-title":"J Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0133","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","article-title":"Grading and staging systems for inflammation and fibrosis in chronic liver diseases","volume":"47","author":"Goodman","year":"2007","journal-title":"J Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0134","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"2026020303253714400_jvim14891-bib-0135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.tvjl.2013.12.017","article-title":"Nutritional management of inherited copper-associated hepatitis in the Labrador retriever","volume":"199","author":"Fieten","year":"2014","journal-title":"Vet J"},{"key":"2026020303253714400_jvim14891-bib-0136","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.tvjl.2012.12.013","article-title":"D-penicillamine treatment of copper-associated hepatitis in Labrador retrievers","volume":"196","author":"Fieten","year":"2013","journal-title":"Vet J"},{"key":"2026020303253714400_jvim14891-bib-0137","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/jvim.14684","article-title":"Interobserver agreement using histological scoring of the canine liver","volume":"31","author":"Lidbury","year":"2017","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0138","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.1840200213","article-title":"A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: Comparison with morphometric studies","volume":"20","author":"Chevallier","year":"1994","journal-title":"Hepatology"},{"key":"2026020303253714400_jvim14891-bib-0139","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0168-8278(98)80318-8","article-title":"Histopathological evaluation of liver fibrosis: Quantitative image analysis vs semi-quantitative scores. Comparison with serum markers","volume":"28","author":"Pilette","year":"1998","journal-title":"J Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0140","article-title":"Canine chronic hepatitis: diagnostic evaluation and complicating syndromes","author":"Lidbury"},{"key":"2026020303253714400_jvim14891-bib-0141","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2007.02.019","article-title":"Non-invasive assessment of chronic liver and gastric diseases","volume":"381","author":"Plebani","year":"2007","journal-title":"Clin Chim Acta"},{"key":"2026020303253714400_jvim14891-bib-0142","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jhep.2004.06.032","article-title":"Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease","volume":"41","author":"Pereira","year":"2004","journal-title":"J Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0143","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ajg.2017.05.005","article-title":"APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: Systematic review and meta-analysis","volume":"18","author":"El Serafy","year":"2017","journal-title":"Arab J Gastroenterol"},{"key":"2026020303253714400_jvim14891-bib-0144","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-230X-11-91","article-title":"Non-invasive markers for hepatic fibrosis","volume":"11","author":"Baranova","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"2026020303253714400_jvim14891-bib-0145","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1292\/jvms.71.1251","article-title":"Blood hyaluronic acid as a marker for canine cirrhosis","volume":"71","author":"Kanemoto","year":"2009","journal-title":"J Vet Med Sci"},{"key":"2026020303253714400_jvim14891-bib-0146","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1515\/pjvs-2015-0113","article-title":"Suitability of using serum hialuronic acid concentrations in the diagnosis of canine liver fibrosis","volume":"18","author":"Glinska-Suchocka","year":"2015","journal-title":"Pol J Vet Sci"},{"key":"2026020303253714400_jvim14891-bib-0147","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1515\/pjvs-2016-0081","article-title":"7S fragment of type IV collagen as a serum marker of canine liver fibrosis","volume":"19","author":"Glinska-Suchocka","year":"2016","journal-title":"Pol J Vet Sci"},{"key":"2026020303253714400_jvim14891-bib-0148","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1515\/pjvs-2016-0045","article-title":"Serum concentrations of PIIINP aminopeptide in dogs with liver fibrosis","volume":"19","author":"Glinska-Suchocka","year":"2016","journal-title":"Pol J Vet Sci"},{"key":"2026020303253714400_jvim14891-bib-0149","first-page":"302","article-title":"Evaluation of hyaluronic acid, procollagen type III N-terminal peptide, and tissue inhibitor of matrix metalloproteinase-1 as serum markers of canine hepatic fibrosis","volume":"80","author":"Lidbury","year":"2016","journal-title":"Can J Vet Res"},{"key":"2026020303253714400_jvim14891-bib-0150","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"2026020303253714400_jvim14891-bib-0151","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1373\/49.3.450","article-title":"Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients","volume":"49","author":"Rossi","year":"2003","journal-title":"Clin Chem"},{"key":"2026020303253714400_jvim14891-bib-0152","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tvjl.2016.04.005","article-title":"Potential of circulating microRNAs as biomarkers in veterinary medicine","volume":"212","author":"Lidbury","year":"2016","journal-title":"Vet J"},{"key":"2026020303253714400_jvim14891-bib-0153","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0034-1397348","article-title":"Circulating microRNAs: Emerging biomarkers of liver disease","volume":"35","author":"Arrese","year":"2015","journal-title":"Semin Liver Dis"},{"key":"2026020303253714400_jvim14891-bib-0154","doi-asserted-by":"crossref","first-page":"e48366","DOI":"10.1371\/journal.pone.0048366","article-title":"Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease","volume":"7","author":"Murakami","year":"2012","journal-title":"PLoS One"},{"key":"2026020303253714400_jvim14891-bib-0155","doi-asserted-by":"crossref","first-page":"e32999","DOI":"10.1371\/journal.pone.0032999","article-title":"Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis","volume":"7","author":"Roderburg","year":"2012","journal-title":"PLoS One"},{"key":"2026020303253714400_jvim14891-bib-0156","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"2026020303253714400_jvim14891-bib-0157","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/jvim.14602","article-title":"Use of serum microRNAs as biomarker for hepatobiliary diseases in dogs","volume":"30","author":"Dirksen","year":"2016","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0158","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0159","doi-asserted-by":"crossref","first-page":"304","DOI":"10.11152\/mu.2013.2066.154.isp23","article-title":"Liver elastography - an update","volume":"15","author":"Sporea","year":"2013","journal-title":"Med Ultrason"},{"key":"2026020303253714400_jvim14891-bib-0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7863\/ultra.33.2.197","article-title":"Shear wave elastography for evaluation of liver fibrosis","volume":"33","author":"Ferraioli","year":"2014","journal-title":"J Ultrasound Med"},{"key":"2026020303253714400_jvim14891-bib-0161","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: A new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"key":"2026020303253714400_jvim14891-bib-0162","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrgastro.2015.224","article-title":"Liver fibrosis in 2015: Crucial steps towards an effective treatment","volume":"13","author":"Poelstra","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0163","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/cs0940557","article-title":"Anti-inflammatory actions of glucocorticoids: Molecular mechanisms","volume":"94","author":"Barnes","year":"1998","journal-title":"Clin Sci"},{"key":"2026020303253714400_jvim14891-bib-0164","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1042\/bst0310060","article-title":"Glucocorticoid suppression of nuclear factor-kappa B: A role for histone modifications","volume":"31","author":"Kagoshima","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"2026020303253714400_jvim14891-bib-0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1513\/pats.200402-001MS","article-title":"Glucocorticoids: Effects on gene transcription","volume":"1","author":"Adcock","year":"2004","journal-title":"Proc Am Thorac Soc"},{"key":"2026020303253714400_jvim14891-bib-0166","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/01652176.2013.826881","article-title":"A retrospective study of oral prednisolone treatment in canine chronic hepatitis","volume":"33","author":"Favier","year":"2013","journal-title":"Vet Q"},{"key":"2026020303253714400_jvim14891-bib-0167","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2460\/javma.1988.193.09.1109","article-title":"Effects of corticosteroid treatment on survival time in dogs with chronic hepatitis: 151 cases (1977-1985)","volume":"193","author":"Strombeck","year":"1988","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303253714400_jvim14891-bib-0168","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cvsm.2009.02.002","article-title":"Therapeutic use of cytoprotective agents in canine and feline hepatobiliary disease","volume":"39","author":"Webster","year":"2009","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303253714400_jvim14891-bib-0169","first-page":"1621","article-title":"Textbook of Veterinary Internal Medicine","author":"Lidbury","year":"2017","edition":"8"},{"key":"2026020303253714400_jvim14891-bib-0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jvim.12002","article-title":"Milk thistle and its derivative compounds: A review of opportunities for treatment of liver disease","volume":"27","author":"Hackett","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0171","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jhep.2009.02.023","article-title":"Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells","volume":"50","author":"Trappoliere","year":"2009","journal-title":"J Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0172","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.4049\/jimmunol.163.12.6800","article-title":"Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis","volume":"163","author":"Manna","year":"1999","journal-title":"J Immunol"},{"key":"2026020303253714400_jvim14891-bib-0173","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1939-1676.1997.tb00090.x","article-title":"Use of ursodeoxycholic acids in a dog with chronic hepatitis: Effects on serum hepatic tests and endogenous bile acid composition","volume":"11","author":"Meyer","year":"1997","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0174","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1096-2867(03)00050-1","article-title":"Current concepts in the treatment of canine chronic hepatitis","volume":"18","author":"Honeckman","year":"2003","journal-title":"Clin Tech Small Anim Pract"},{"key":"2026020303253714400_jvim14891-bib-0175","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hep.20870","article-title":"Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-beta1-induced apoptosis in rat hepatocytes","volume":"42","author":"Sola","year":"2005","journal-title":"Hepatology"},{"key":"2026020303253714400_jvim14891-bib-0176","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.2174\/092986706778521823","article-title":"Modulation of hepatocyte apoptosis: Cross-talk between bile acids and nuclear steroid receptors","volume":"13","author":"Sola","year":"2006","journal-title":"Curr Med Chem"},{"key":"2026020303253714400_jvim14891-bib-0177","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0035-1571273","article-title":"Primary biliary cirrhosis beyond ursodeoxycholic acid","volume":"36","author":"Corpechot","year":"2016","journal-title":"Semin Liver Dis"},{"key":"2026020303253714400_jvim14891-bib-0178","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12917-015-0453-2","article-title":"Hepatopathy following consumption of a commercially available blue-green algae dietary supplement in a dog","volume":"11","author":"Bautista","year":"2015","journal-title":"BMC Vet Res"},{"key":"2026020303253714400_jvim14891-bib-0179","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1748-5827.2003.tb00126.x","article-title":"Diagnosis and management of hepatic copper accumulation in a Skye terrier","volume":"44","author":"McGrotty","year":"2003","journal-title":"J Small Anim Pract"},{"key":"2026020303253714400_jvim14891-bib-0180","first-page":"109","article-title":"Effects of colchicine and colchiceine in a biochemical model of liver injury and fibrosis","volume":"29","author":"Rodriguez","year":"1998","journal-title":"Arch Med Res"},{"key":"2026020303253714400_jvim14891-bib-0181","first-page":"281","article-title":"Colchicine treatment of liver fibrosis","volume":"53","author":"Nikolaidis","year":"2006","journal-title":"Hepatogastroenterology"},{"key":"2026020303253714400_jvim14891-bib-0182","first-page":"CD002148","article-title":"Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis","author":"Rambaldi","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2026020303253714400_jvim14891-bib-0183","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1742-7843.2005.pto_06.x","article-title":"Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: Effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid","volume":"96","author":"Muriel","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2026020303253714400_jvim14891-bib-0184","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2460\/javma.1984.185.03.303","article-title":"Colchicine therapy for hepatic fibrosis in a dog","volume":"185","author":"Boer","year":"1984","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303253714400_jvim14891-bib-0185","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5326\/JAAHA-MS-6080","article-title":"Adverse interaction between colchicine and ketoconazole in a Chinese shar pei","volume":"50","author":"McAlister","year":"2014","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020303253714400_jvim14891-bib-0186","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3565(25)05084-0","article-title":"Colchicine. I. General pharmacology","volume":"106","author":"Ferguson","year":"1952","journal-title":"J Pharmacol Exp Ther"},{"key":"2026020303253714400_jvim14891-bib-0187","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.3748\/wjg.15.2579","article-title":"Renin-angiotensin system in the pathogenesis of liver fibrosis","volume":"15","author":"Pereira","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2026020303253714400_jvim14891-bib-0188","doi-asserted-by":"crossref","first-page":"G726","DOI":"10.1152\/ajpgi.00162.2009","article-title":"Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C","volume":"297","author":"Colmenero","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2026020303253714400_jvim14891-bib-0189","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s10620-010-1507-8","article-title":"The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort","volume":"56","author":"Abu Dayyeh","year":"2011","journal-title":"Dig Dis Sci"},{"key":"2026020303253714400_jvim14891-bib-0190","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/jvim.12471","article-title":"Telmisartan treatment of refractory proteinuria in a dog","volume":"28","author":"Bugbee","year":"2014","journal-title":"J Vet Intern Med"},{"key":"2026020303253714400_jvim14891-bib-0191","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-230X-14-131","article-title":"Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C","volume":"14","author":"Flores-Contreras","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"2026020303253714400_jvim14891-bib-0192","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2885.2004.00612.x","article-title":"Pharmacokinetics of orally administered pirfenidone in male and female beagles","volume":"27","author":"Bruss","year":"2004","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020303253714400_jvim14891-bib-0193","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.diff.2016.07.001","article-title":"The characteristics of activated portal fibroblasts\/myofibroblasts in liver fibrosis","volume":"92","author":"Karin","year":"2016","journal-title":"Differentiation"},{"issue":"1","key":"2026020303253714400_jvim14891-bib-0194","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1440-1746.2011.07002.x","article-title":"What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis","volume":"27","author":"Iwaisako","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0195","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jhep.2006.04.014","article-title":"Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis","volume":"45","author":"Kisseleva","year":"2006","journal-title":"J Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0196","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1746-6148-8-150","article-title":"Comparison of bone marrow and adipose tissue-derived canine mesenchymal stem cells","volume":"8","author":"Takemitsu","year":"2012","journal-title":"BMC Vet Res"},{"key":"2026020303253714400_jvim14891-bib-0197","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/hep.1840200224","article-title":"Involvement of annexin I and annexin II in hepatocyte proliferation: Can annexins I and II be markers for proliferative hepatocytes?","volume":"20","author":"Masaki","year":"1994","journal-title":"Hepatology"},{"key":"2026020303253714400_jvim14891-bib-0198","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jb\/mvm248","article-title":"Annexin A3 expression increases in hepatocytes and is regulated by hepatocyte growth factor in rat liver regeneration","volume":"143","author":"Harashima","year":"2008","journal-title":"J Biochem"},{"key":"2026020303253714400_jvim14891-bib-0199","doi-asserted-by":"crossref","first-page":"G765","DOI":"10.1152\/ajpgi.00308.2005","article-title":"Secretion of MCP-1\/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts","volume":"290","author":"Kruglov","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2026020303253714400_jvim14891-bib-0200","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1159\/000374096","article-title":"Pathophysiology of liver fibrosis","volume":"33","author":"Pinzani","year":"2015","journal-title":"Dig Dis"},{"key":"2026020303253714400_jvim14891-bib-0201","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J Hepatol"},{"key":"2026020303253714400_jvim14891-bib-0202","doi-asserted-by":"crossref","first-page":"G391","DOI":"10.1152\/ajpgi.00167.2007","article-title":"The liver sinusoidal endothelial cell: A cell type of controversial and confusing identity","volume":"294","author":"Elvevold","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2026020303253714400_jvim14891-bib-0203","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fimmu.2016.00521","article-title":"NCR1 Expression identifies canine natural killer cell subsets with phenotypic similarity to human natural killer cells","volume":"7","author":"Foltz","year":"2016","journal-title":"Front Immunol"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.14891","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/32\/1\/26\/66672510\/jvim14891.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/32\/1\/26\/66672510\/jvim14891.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:26:15Z","timestamp":1770107175000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/32\/1\/26\/8449724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":203,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.14891","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2018,1,1]]}}}